Global Lactoferrin Market Overview to 2027

DUBLIN, January 18, 2022 /PRNewswire/ — The report “Global Lactoferrin Market by Function, By Application, By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021-2027” has been added to from offer.

Research and Markets Logo

The global lactoferrin market size is expected to reach $408 million by 2027, growing the market at 8.5% CAGR during the forecast period.

Lactoferrin has stimulating effects on the immune system and also prevents cell damage caused by aging. Additionally, it supports the cultivation of helpful bacteria in the intestinal tract and controls viruses, bacteria and fungi, as well as being a regulator of iron metabolism. Lactoferrin has been shown to be effective in the treatment of hepatitis C by suppressing multiplication of the virus intracellularly. Hence, lactoferrin finds potential applications in personal care, nutraceutical, and pharmaceutical industries, thereby driving the growth of the lactoferrin market over the forecast period.

Demand for the product is expected to be propelled by increased consumer health and diet awareness, combined with the growing occurrence of skin-related health issues. Lactoferrin has been proven to exhibit antiviral, antiparasitic, antibacterial, antiallergic and catalytic functions and properties. According to the American Academy of Dermatology, acne is the most common skin condition in the United States, affecting more than 40 to 50 million people nationwide each year. The acne treatment market is also expected to witness massive growth throughout the forecast period.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic has boosted demand for supplements. There is a higher demand among consumers to boost immune health, support their bodies and reduce anxiety. The retail store remained closed due to strict lockdown conditions; therefore, online channels are used to meet the changing needs of customers. Due to the ever-increasing demand, manufacturers are facing different kinds of problems in terms of raw material supply.

Companies are adopting preventive measures to meet consumer needs and also facilitate worker safety. All the organizations comply with the standards and regulations formulated by the government bodies to open the stores. They provide gloves, sanitizers and masks to store employees to keep them safe. Organizations are reducing store hours and urging customers to adhere to social distancing norms and use contactless payments.

Market Growth Factors:

Rise in the number of working women and growing concerns about child nutrition

Lactoferrin is heavily used in infant formula due to its ability to boost the infant’s immune system by enhancing anti-inflammatory and anti-infective activities and better absorption of iron in the infant’s gut. An increase in consumer awareness of the importance of child health and nutrition, along with the growing number of working women, is expected to create new growth avenues for lactoferrin in the global market.

Several Benefits of Lactoferrin

Lactoferrin helps control how iron mixes in the body from the gut. It also fights against infections caused by viruses, bacteria and fungi. Lactoferrin has been proven to limit the growth of bacteria by not providing them with nutrients. It also eliminates the walls around bacteria. The lactoferrin available in breast milk is considered to help breastfed infants against infections. Lactoferrin is also helpful in the generation of blood cells and the body’s ability to fight infections.

Market Restraint Factor:

Low availability of lactoferrin products

Both underdeveloped and developing countries have low availability of lactoferrin products which is expected to hamper the demand and growth of the lactoferrin market over the forecast period. Additionally, these countries have weak presence of key market players which further hamper the global lactoferrin market during the forecast period.

Job prospects

Based on function, the market is segmented into iron absorption, gut flora protection, immune cell stimulation, antioxidant, antibacterial, and anti-inflammatory. The antibacterial feature segment garnered the major revenue share of the market in 2020. The growth of the segment is expected to be accelerated by the product’s ability to restrain bacterial growth and biofilm formation, which will lead to an increase in its use in as antimicrobial therapy. agent. Pharmaceutical organizations have witnessed the inclusion of lactoferrin as an active ingredient in various antibacterial and antimicrobial products.

Application Outlook

Based on application, the market is segmented into Pharmaceuticals, Food & Beverages, Personal Care Products, Infant Formula, Sports & Functional Foods, and Pet Foods. The infant formula segment has acquired the largest revenue share from the lactoferrin market in 2020. Additionally, the segment is expected to exhibit significant growth rate during the forecast period. Factors such as the steady increase in the number of clinical studies encouraging the inclusion of lactoferrin in infant formulas and changing consumer trends towards infant food supplements are responsible for the growth of this segment.

Regional outlook

Based on regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2020, the Asia Pacific garnered the maximum revenue share from the lactoferrin market. Moreover, the regional market is expected to exhibit a similar type of trend even during the forecast period. India, Japan, and China are the leading countries in the region, and the steady population growth and increasing consumer purchasing power are the catalysts for the growth of the regional market.

The market research report covers the analysis of major market players. Key companies profiled in the report include Royal FrieslandCampina NV, Glanbia PLC, Fonterra Co-operative Group Limited, Morinaga Milk Industry Co., Ltd., Ventria Bioscience, Inc. (InVitria), Farbest Brands, Bega Cheese Ltd (Tatura Milk Industries Ltd.), MP Biomedicals LLC (Valiant Co., Ltd.), Synlait Milk Limited and Pharming Group NV.

Main topics covered:

Chapter 1. Market Scope and Methodology

Chapter 2. Market Overview
2.1 Presentation
2.1.1 Presentation Impact of COVID-19 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market constraints

Chapter 3. Global Lactoferrin Market by Function
3.1 Global Iron Absorption Market by Region
3.2 Global Gut Flora Protection Market by Region
3.3 Global Immune Cell Stimulation Market by Region
3.4 Global Antioxidants Market by Region
3.5 Global Antibacterials Market by Region
3.6 Global Anti-inflammatory Drugs Market by Region

Chapter 4. Global Lactoferrin Market by Application
4.1 Global Pharmaceuticals Market by Region
4.2 Global Food and Beverages Market by Region
4.3 Global Personal Care Products Market by Region
4.4 Global Infant Formula Market by Region
4.5 Global Sports and Functional Foods Market by Region
4.6 Global Animal Feed Market by Region

Chapter 5. Global Lactoferrin Market by Region

Chapter 6. Business Profiles
6.1 Royal FrieslandCampina AG
6.1.1 Presentation of the company
6.1.1 Financial analysis
6.1.2 Sectoral and regional analysis
6.1.3 Research & Development costs
6.1.4 Strategies and recent developments: Partnerships, collaborations and agreements: Product launches and product extensions:
6.2 Glanbia PLC
6.2.1 Presentation of the company
6.2.2 Financial analysis
6.2.3 Sectoral and regional analysis
6.2.4 Research & Development costs
6.3.3 Sectoral and regional analysis
6.4 Morinaga Milk Industry Co., Ltd.
6.4.1 Presentation of the company
6.4.2 Financial analysis
6.4.3 Segmental analysis
6.4.4 Research & Development expenses
6.4.5 Strategies and recent developments: Partnerships, collaborations and agreements: Geographic expansions:
6.5 Ventria Bioscience, Inc. (InVitria)
6.5.1 Presentation of the company
6.6 Top Brands
6.6.1 Presentation of the company
6.7 Bega Cheese Ltd (Tatura Milk Industries Ltd.)
6.7.1 Presentation of the company
6.7.2 Financial analysis
6.7.3 Sectoral and regional analysis
6.7.4 Strategies and recent developments: Product launches and product extensions: Geographic extensions:
6.8 MP Biomedicals LLC (Valiant Co., Ltd.)
6.8.1 Company overview
6.9 Synlait Limited
6.9.1 Company Overview
6.9.2 Financial analysis
6.9.3 Regional Analysis
6.9.4 Strategies and recent developments: Partnerships, collaborations and agreements: Geographic extensions:
6.10. Pharming Group S.A.
6.10.1 Company overview
6.10.2 Financial analysis
6.10.3 Regional Analysis
6.10.4 Research and development costs

For more information on this report visit

Media Contact:

Research and Markets
Laura Wood, senior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716



View original content:—featuring-glanbia-ventria-bioscience-and-mp-biomedicals – among-others-301462756.html

SOURCE Research and Markets

About Sally Dominguez

Check Also

FDA approves first systemic treatment for alopecia

FDA announced on Monday that it has approved baricitinib, a drug manufactured by Eli Lily …